SHSE:603858 (China)
Â
Class A
Â¥
15.13
(+0.53%)
Jun 7
Current and historical daily PE Ratio for Shandong Buchang Pharmaceuticals Co Ltd (
SHSE:603858
) from 2016 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Shandong Buchang Pharmaceuticals stock (SHSE:603858) PE ratio as of Jun 08 2024 is 0.
More Details
Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) PE Ratio (TTM) Chart
Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 1204
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Shandong Buchang Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | At Loss | 2024-04-02 | At Loss |
| 2024-06-07 | At Loss | 2024-04-01 | At Loss |
| 2024-06-06 | At Loss | 2024-03-29 | At Loss |
| 2024-06-05 | At Loss | 2024-03-28 | At Loss |
| 2024-06-04 | At Loss | 2024-03-27 | 57.1 |
| 2024-06-03 | At Loss | 2024-03-26 | 57.9 |
| 2024-05-31 | At Loss | 2024-03-25 | 57.9 |
| 2024-05-30 | At Loss | 2024-03-22 | 59.2 |
| 2024-05-29 | At Loss | 2024-03-21 | 60.5 |
| 2024-05-28 | At Loss | 2024-03-20 | 60.8 |
| 2024-05-27 | At Loss | 2024-03-19 | 60.8 |
| 2024-05-24 | At Loss | 2024-03-18 | 61.6 |
| 2024-05-23 | At Loss | 2024-03-15 | 61.6 |
| 2024-05-22 | At Loss | 2024-03-14 | 61.3 |
| 2024-05-21 | At Loss | 2024-03-13 | 61.5 |
| 2024-05-20 | At Loss | 2024-03-12 | 61.4 |
| 2024-05-17 | At Loss | 2024-03-11 | 60.3 |
| 2024-05-16 | At Loss | 2024-03-08 | 59.8 |
| 2024-05-15 | At Loss | 2024-03-07 | 59.8 |
| 2024-05-14 | At Loss | 2024-03-06 | 60.4 |
| 2024-05-13 | At Loss | 2024-03-05 | 60.0 |
| 2024-05-10 | At Loss | 2024-03-04 | 60.4 |
| 2024-05-09 | At Loss | 2024-03-01 | 59.5 |
| 2024-05-08 | At Loss | 2024-02-29 | 59.6 |
| 2024-05-07 | At Loss | 2024-02-28 | 59.1 |
| 2024-05-06 | At Loss | 2024-02-27 | 60.1 |
| 2024-04-30 | At Loss | 2024-02-26 | 59.8 |
| 2024-04-29 | At Loss | 2024-02-23 | 59.5 |
| 2024-04-26 | At Loss | 2024-02-22 | 58.9 |
| 2024-04-25 | At Loss | 2024-02-21 | 58.3 |
| 2024-04-24 | At Loss | 2024-02-20 | 57.8 |
| 2024-04-23 | At Loss | 2024-02-19 | 57.6 |
| 2024-04-22 | At Loss | 2024-02-16 | 58.3 |
| 2024-04-19 | At Loss | 2024-02-09 | 58.3 |
| 2024-04-18 | At Loss | 2024-02-08 | 58.3 |
| 2024-04-17 | At Loss | 2024-02-07 | 58.8 |
| 2024-04-16 | At Loss | 2024-02-06 | 56.2 |
| 2024-04-15 | At Loss | 2024-02-05 | 52.5 |
| 2024-04-12 | At Loss | 2024-02-02 | 50.9 |
| 2024-04-11 | At Loss | 2024-02-01 | 52.3 |
| 2024-04-10 | At Loss | 2024-01-31 | 52.3 |
| 2024-04-09 | At Loss | 2024-01-30 | 53.3 |
| 2024-04-08 | At Loss | 2024-01-29 | 54.8 |
| 2024-04-05 | At Loss | 2024-01-26 | 55.3 |
| 2024-04-03 | At Loss | 2024-01-25 | 55.6 |
Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Shandong Buchang Pharmaceuticals Co Ltd
ISIN : CNE100002FV6
Share Class Description:
SHSE:603858: Class ACompare
Compare
Traded in other countries / regions
603858.China IPO Date
2016-11-08Description
Shandong Buchang Pharmaceuticals Co Ltd is a pharmaceuticals company engaged in drug manufacturing. It specializes in the research and development, production and sale of Traditional Chinese patent medicines, supplemented by fields such as hi-tech industry and health industry. The company offers drugs for cardiac and cerebral vascular disease, diabetes, urinary and digestive disease, respiratory disease, gynecological disease and others. Geographically, the company holds its production bases in Shandong, Shaanxi, Hebei and Northeast China, with its marketing network spreading all over the major provinces of China.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers